INGN(Inogen, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $358.00M | $377.24M | $315.66M | $335.70M | $348.67M |
| 毛利润 | $176.48M | $153.53M | $126.70M | $154.74M | $154.26M |
| 营业利润 | $9.24M | −$85.24M | −$109.39M | −$42.52M | −$30.21M |
| 净利润 | −$6.33M | −$83.77M | −$102.45M | −$35.89M | −$22.75M |
| 经营现金流 | $23.63M | −$37.53M | −$3.23M | $5.91M | −$11.22M |
| 自由现金流 | $18.15M | −$40.87M | −$8.45M | $2.55M | −$13.74M |
| 摊薄每股收益 | $-0.28 | $-3.67 | $-4.42 | $-1.52 | $-0.86 |